Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Needle-Free Drug Delivery Devices Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The needle-free drug delivery devices market size has seen swift expansion in recent years. It is projected to increase from $16.7 billion in 2024 to $18.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.0%. The historical growth can be attributed to the growing prevalence of chronic diseases, a heightened demand for painless methods of drug administration, a substantial geriatric population, increased emphasis on patient compliance and safety, regulatory encouragement for needle-free technologies, and the expansion of the pharmaceutical industry.
The market for needle-free drug delivery devices is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $27.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.5%. Key factors contributing to this anticipated growth include a heightened demand for medication delivery without pain, a stronger focus on healthcare approaches centered around patients, broader utility across child and elderly patient groups, an increase in chronic illnesses requiring regular injections, improvements in technology that boost device effectiveness and ease of use, improved healthcare accessibility in developing economies, and increased funding for research and development into novel delivery methods. Significant trends expected during this period involve a rise in the use of wearable and interconnected devices, the introduction of innovative microfluidic technologies, a greater emphasis on needle-free options suitable for children, the incorporation of artificial intelligence and machine learning, and broader utilization within home healthcare environments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
Which Industry Drivers Are Expected To Accelerate The Needle-Free Drug Delivery Devices Market From 2025 To 2029?
The rising incidence of diabetes is anticipated to fuel the expansion of the needle-free drug delivery device market. Diabetes is a chronic health condition characterized by elevated blood sugar levels, stemming from inadequate insulin production or the body’s ineffective utilization of insulin. This increase in diabetes cases is attributed to factors like inactive lifestyles, poor eating habits, genetic predisposition, urbanization, and aging populations, alongside restricted healthcare access and growing global obesity rates. For diabetes management, needle-free drug delivery devices offer an alternative method for administering insulin, replacing traditional injections. These devices employ technologies such as jet injectors or transdermal patches to deliver insulin through the skin without needles, thereby reducing the discomfort and anxiety frequently associated with injections and enhancing patient comfort. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the expanding prevalence of diabetes is driving the growth of the needle-free drug delivery device market.
How Is The Needle-Free Drug Delivery Devices Market Classified Into Different Segments?
The needle-free drug delivery devicesmarket covered in this report is segmented –
1) By Device Type: Inhalers; Jet Injectors; Novel Needles; Transdermal Patches; Other Device Types
2) By Application: Pain Management; Vaccine Delivery; Pediatric Injections; Insulin Delivery; Other Applications
3) By End-User: Hospitals And Clinics; Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi); Metered Dose Inhalers (Mdi); Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors; Spring-Powered Jet Injectors; Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays; Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches; Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices; Implantable Drug Delivery Systems; Sublingual Drug Delivery Devices
What Long-Term Trends Will Shape The Future Growth Of The Needle-Free Drug Delivery Devices Industry?
Leading companies in the needle-free drug delivery device market are concentrating on advanced solutions, such as dual-chamber inhalers, to enhance efficacy, simplify administration, and address the evolving requirements of patients and healthcare providers. A dual-chamber inhaler is a system comprising two separate compartments designed to hold different medications. This configuration allows for the integration of multiple drugs into a single inhaler, thereby streamlining treatment and improving patient convenience. For example, in April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, an innovative dry powder inhaler (DPI) engineered to revolutionize patient-centered healthcare solutions. This dual-chamber inhaler features a dose counter, ensuring precise medication delivery. Its entirely plastic construction, free from any metal parts, makes it ideal for complex inhalation treatments, simplifying dosage and effectively combining various drugs. Its advanced attributes include a bi-directional mouthpiece cover for convenience and hygiene, alongside audible signals to indicate proper usage. The integrated dose counter assists in accurately monitoring medication consumption, thereby preventing dosing errors.
Who Are The Major Companies Operating In The Needle-Free Drug Delivery Devices Market?
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Needle-Free Drug Delivery Devices Market?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Needle-Free Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp
Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2025, By The Business Research Company
Microneedle Drug Delivery Systems Global Market Report 2025
Hypodermic Syringes And Needles Global Market Report 2025
Injectable Drug Delivery Devices Market 2025
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model